Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia
Clinical Trial to Compare Topical Interferon Alfa 2b And Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia
Sponsor: Coordinación de Investigación en Salud, Mexico
This PHASE4 trial investigates Conjunctival Intraepithelial Neoplasia and Corneal Intraepithelial Neoplasia and is currently completed. Coordinación de Investigación en Salud, Mexico leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Aug 2017 — Jun 2018 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
▶ Show 2 earlier versions
-
Feb 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Coordinación de Investigación en Salud, Mexico
- Instituto Mexicano del Seguro Social
- University of Guadalajara
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Guadalajara, Mexico